Back
Illumina Inc (ILMN)
Life Sciences Tools & ServicesILMN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$278.08
+5.18%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$5.45
ROE
33.8%
Gross margin
68.3%
Debt/Equity
0.95x
Revenue growth
4.8%
Illumina Inc — company intelligence
Earnings surprises
Q2 2026$1.31 vs $1.25 est+4.7%
Q1 2026$1.15 vs $1.08 est+6.9%
Q4 2025$1.15 vs $1.08 est+6.9%
Q3 2025$1.34 vs $1.19 est+12.7%
Analyst consensus · 28 analysts
16 Buy9 Hold3 Sell
Updated Oct 6, 2026
Insider activity · 90 days
5 buys70 sellsnet -2,028,431 shares
Coletti Julie AnnBuy 5,307 · Sep 8, 2026
Coletti Julie AnnBuy 14,214 · Sep 8, 2026
Coletti Julie AnnBuy 4,549 · Sep 8, 2026
Recent SEC filings
4 — Insider transaction reportSep 10, 2026
4 — Insider transaction reportSep 9, 2026
4 — Insider transaction reportSep 4, 2026
Latest news
What Needs To Be True To Buy Twist Bioscience Stock Now? — Yahoo · 2w ago
Analysts Think 6 S&P 500 Stocks Are Grossly Overvalued — Yahoo · 2w ago
3 Healthcare Stocks with Warning Signs — Yahoo · 2w ago
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today — Benzinga · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.